PHOENICIA ROWE: Open Payments
NPI 1891338471 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 63 payments from 9 companies in 2025. Trend: 2023 $734 · 2024 $1,406 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 30 | $288 |
| Collegium Pharmaceutical, Inc. | 23 | $251 |
| Abbott Laboratories | 3 | $57 |
| PROTEGA PHARMACEUTIALS INC | 2 | $56 |
| Averitas Pharma Inc. | 1 | $27 |
| Avanos Medical | 1 | $23 |
| MML US, Inc. | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: RELISTOR, XTAMPZA, ROXYBOND, Belbuca, PROCLAIM, QUTENZA, GENERATOR, ReActiv8.
Industry payments across AZ — which companies pay providers there.
